共 122 条
[1]
Röllig C(2015)Multiple myeloma Lancet 385 2197-2208
[2]
Knop S(1998)Combination chemotherapy plus prednisone as treatment for multiple myeloma. An overview of 6.633 patients from 27 randomized trials J Clin Oncol 16 3832-3842
[3]
Bornhaüser M(1996)A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma N Engl J Med 335 91-97
[4]
Attal M(2003)High dose chemotherapy with hematopoetic stem-cell rescue for multiple myeloma N Engl J Med 348 1875-1883
[5]
Harrousseau JL(2007)High dose treatment with autologous stem cell transplantation in multiple myeloma: past, present and future Semin Hematol 44 227-233
[6]
Stoppa AM(2001)Health-related quality of life in multiple myeloma receiving high dose chemotherapy with autologous blood stem- cell support Med Oncol 18 65-77
[7]
Sotto JJ(2006)Intensive therapy for multiple myeloma in patients younger than 60 years. Long term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation Haematologica 91 1228-1233
[8]
Fuzibet JG(2006)Nordic myeloma study group. Impact of age on survival of intensive therapy for multiple myeloma: a population based study by the Nordic myeloma study group Br J Haematol 133 389-396
[9]
Rossi JF(1999)Antitumor activity of thalidomide in refractory multiple myeloma N Engl J Med 341 1565-1571
[10]
Child JA(2003)A phase II study of bortezomib in relapsed, refractory myeloma N Engl J Med 348 2609-2617